Skip to main content
INGN
NASDAQ Industrial Applications And Services

Inogen Reports Positive Q2 Adjusted EBITDA, Raises Full-Year Guidance, and Repurchases $7.5M in Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$6.383
Mkt Cap
$175.714M
52W Low
$5.34
52W High
$9.13
52W Position info
20% above low
Off High info
30% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

INGN sits 20% above its 52-week low of $5.34.

Summary

Inogen announced strong Q2 2026 financial results, including positive Adjusted EBITDA and raised full-year guidance, alongside active share repurchases.


Key Events · Earnings and Guidance · INGN

  • Positive Q2 Adjusted EBITDA

    Reported positive Adjusted EBITDA of $2.4 million for the second quarter of 2026, a 15.2% increase year-over-year and a significant improvement from the negative Adjusted EBITDA in Q1 2026.

  • Raised Full-Year Adjusted EBITDA Guidance

    Increased full-year 2026 Adjusted EBITDA guidance to approximately $4.0 million, representing a 48.1% increase from $2.7 million reported in 2025.

  • Active Share Repurchase Program

    Repurchased 1,145,150 shares of common stock for $7.5 million in the first half of 2026 under its previously announced program, demonstrating capital allocation to shareholders.

  • Revenue Growth and International Expansion

    Achieved Q2 2026 revenue of $95.1 million, a 3.0% year-over-year increase, driven by strong international revenue growth of 14.8%.


Analysis · INGN · Industrial Applications And Services

Inogen reported a significant turnaround in profitability, achieving positive Adjusted EBITDA of $2.4 million in Q2 2026, a notable improvement from the negative Adjusted EBITDA in the prior quarter. This positive momentum led to a substantial increase in full-year Adjusted EBITDA guidance by 48.1% from 2025 levels. The company also actively repurchased $7.5 million of its common stock in the first half of 2026, signaling management's confidence and commitment to shareholder value.

How filings like this one have moved

In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INGN was trading at $6.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $175.7M. The 52-week trading range was $5.34 to $9.13. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INGN - Latest Insights

INGN
Aug 07, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.05
Real-time Price: $5.13 info
Change: -$0.920 (-15%) info
Market Cap: $136.142M info
INGN
Aug 06, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.13 info
Change: -$0.970 (-16%) info
Market Cap: $136.142M info
INGN
Jul 01, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.70
Real-time Price: $5.13 info
Change: -$1.57 (-23%) info
Market Cap: $136.142M info
INGN
Jun 11, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $5.13 info
Change: -$1.00 (-16%) info
Market Cap: $136.142M info
INGN
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $5.13 info
Change: -$1.89 (-27%) info
Market Cap: $136.142M info